New hope for restless legs sufferers whose medication backfires
NCT ID NCT03218969
First seen Apr 27, 2026 · Last updated May 25, 2026 · Updated 5 times
Summary
This small study tested a drug called ecopipam in 10 adults with restless legs syndrome whose symptoms had gotten worse from their usual dopamine medication. The goal was to see if ecopipam could reduce symptom severity and the spread of symptoms to other body parts. Each person took ecopipam for 6 weeks and a placebo for 6 weeks, with a 2-week break in between, to compare the effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEGS SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.